Latest News

  • Klikdokter Supports Indonesian Doctors Association (IDI) in COVID-19 Handling

    Wednesday, July 22, 2020
    Klikdokter Supports Indonesian Doctors Association (IDI) in COVID-19 Handling

    Jakarta, 22 July 2020, PT Kalbe Farma Tbk (Kalbe) through its subsidiary KlikDokter supports the Indonesian Doctors Association (IDI) through multivitamin assistance to medical personnel in fighting COVID-19. Klikdokter as one of the national health education media that has been appointed by the Ministry of Health of the Republic of Indonesia will also provide education and assistance to the government in providing correct information related to COVID-19.

  • Kalbe Launches Vitamin D3 to Maintain Body Stamina

    Thursday, July 9, 2020
    Kalbe Launches Vitamin D3 to Maintain Body Stamina

    Jakarta, July 9, 2020, PT Kalbe Farma Tbk (Kalbe) launched the Prove D3, a vitamin D3 supplement in the form of liquid drops. The launch of the vitamin D3 is marked by health education activities through the Vitamin D3 Webinar Media Series that takes the theme “New Normal: Is Taking Vitamins Still Necessary?” This webinar presented the speakers: Dr. Aditya Susilo, SpPD-KPTI, Division of Tropical and Infectious Diseases, Department of Internal Medicine of FKUI/RSUPN dr. Cipto Mangunkusumo who is also a member of the COVID-19 Task Force Team of Medical Experts; and Dr. Cindiawaty Pudjiadi, MARS, MS, Sp. GK, Clinical Nutritionist Specialist at Medistra Hospital; and Tekla Rosa Oktivia, Product Manager of PT Kalbe Farma Tbk.

  • Kalbe Innovates Through Herbal Medicine to Strengthen Body Immunity in the New Normal Era

    Wednesday, July 1, 2020
    Kalbe Innovates Through Herbal Medicine to Strengthen Body Immunity in the New Normal Era

    Jakarta, July 1, 2020, PT Kalbe Farma Tbk (Kalbe) through the Kalbe Consumer Health division with the Health & Happiness (H2) product Cordyceps militaris held health education to strengthen the body's immunity with the theme “Resilience in Facing the New Normal. ” This theme was raised to further optimize the awareness of the Indonesian people to remain vigilant of COVID-19. The health education presented guest speakers Prof. Widodo, S.Sc., S.Sc., Ph.D. Med.Sc., as a Professor of the Faculty of Mathematics and Natural Sciences and Biomolecular Experts of Brawijaya University, Malang; and dr. Moh. Adib Khumaidi, SpOT, Chairperson of the Indonesian Emergency Doctors Association/PDEI; as well as dr. Helmin Agustina Silalahi, Medical Manager of the Kalbe Consumer Health Division of PT Kalbe Farma Tbk. 

  • Herbal Medicine Clinical Trial as Immunomodulators on COVID-19 Patients

    Thursday, June 11, 2020
    Herbal Medicine Clinical Trial as Immunomodulators on COVID-19 Patients

    Jakarta, June 11, 2020 - PT Kalbe Farma Tbk (Kalbe) took part in clinical trials on herbal medicines made from Indonesian biodiversity as herbal immunomodulatory products in the handling of COVID-19 patients that is coordinated by the Covid-19 Research Consortium/BRIN. The 2 products that will take part in the clinical trial are products based on Cordyceps militaris and a combination of extracted ingredients made from extracts of red ginger, gripeweed, Green chiretta, and Ngai camphor. The clinical trial is a collaboration of the Indonesian Institute of Sciences (LIPI), Kalbe, Gadjah Mada University (UGM), and the Association of Indonesian Traditional Medicine and Herbal Medicine Developers (PDPOTJI). 

  • Kalbe Collaborates with Genexine of South Korea to Develop COVID-19 Vaccines

    Wednesday, May 27, 2020
    Kalbe Collaborates with Genexine of South Korea to Develop COVID-19 Vaccines

    Jakarta, May 27, 2020, PT Kalbe Farma Tbk (Kalbe) signed a memorandum of understanding with Genexine, Inc., a biological drug company from South Korea to develop a vaccine for the new corona virus or Covid-19 . Kalbe and Genexine has agreed to conduct GX-19 clinical trials in Indonesia, that is the development of DNA vaccines against new corona virus, to be carried out by the consortium of Genexine, Binex, the International Vaccine Institute (IVI), GenNBio, the Korea Advanced Institute of Science & Technology (KAIST), and Pohang University of Science & Technology (POSTECH). Covid-19 vaccine clinical trial is planned to be conducted in June 2020. 

RSS
12345Last